Human Growth Factor I Kit

Application(s)		Cardiovascular
Analyte(s)		FGF (basic), PlGF, VEGF-A, VEGFR-1/Flt-1
Species		Human
Instrument(s)		SECTOR Imager 2400 , MESO SECTOR S 600MM , SECTOR Imager 6000 , MESO QuickPlex SQ 120MM , MESO QuickPlex SQ 120 , MESO SECTOR S 600
Plate Type		96-well
Capture Antibody		bFGF: Mouse Monoclonal VEGFR-1 (sFlt-1): Mouse Monoclonal PlGF: Mouse Monoclonal VEGF: Goat Polyclonal
Detection Antibody		bFGF: Mouse Monoclonal VEGFR-1 (sFlt-1): Goat Polyclonal PlGF: Goat Polyclonal VEGF: Mouse Monoclonal
LLOD (Sensitivity)		bFGF: 2.2 pg/mL VEGFR-1 (sFlt-1): 8.9 pg/mL PlGF: 0.96 pg/mL VEGF: 6.4 pg/mL
Dynamic Range		bFGF: 2.2-9000 pg/mL VEGFR-1 (sFlt-1): 8.9-9000 pg/mL PlGF: 0.96-9000 pg/mL VEGF: 6.4-9000pg/mL
Sample Type		Serum, Plasma
Recombinant standards		bFGF: Recombinant Human bFGF VEGFR-1 (sFlt-1): Recombinant Human VEGF R1/Flt-1/Fc Chimera PlGF: Recombinant Human PlGF VEGF: hVEGF 165 aa variant expressed in Sf 21 insect cells using baculovirus expression system.
Usage Statement		For Research Use Only. Not for use in diagnostic procedures.
Storage Statement(s)		Please refer to the product insert for the storage conditions of individual kit components.
Storage Condition		Multi-Component
Schedule B Code		3002.15.0100

Product Inserts		Human Growth Factor I
Datasheets		DS Growth Factor I
Certificate of analysis		K0050620
SDS		Diluent 2, Diluent 3, Diluent 5, Diluent 7 and Diluent 8 MSD Calibrators and Controls Read Buffer T (4x), Read Buffer S (4x) and Read Buffer S (1x)

Title	Journal	Year
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection Najmeh Bozorgmehr, Siavash Mashhouri, Eliana Perez Rosero, Lai Xu, Shima Shahbaz, Wendy Sligl, Mohammed Osman, Demetrios J. Kutsogiannis, Erika MacIntyre, Conar R. O’Neil, Shokrollah Elahi	mBio	2021
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial G B Sigal, M R Segal, A Mathew, L Jarlsberg, M Wang, S Barbero, N Small, K Haynesworth, J L Davis, M Weiner, W C Whitworth, J Jacobs, J Schorey, D M Lewinsohn, P Nahid	EBioMedicine	2017
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga TW, Allaart CF.	Rheumatology (Oxford)	2013
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2 in patients with advanced hepatocellular cancer. Zhu AX, Finn RS, Mulcahy M, Gurtler J, Sun W, Schwartz JD, Dalal RP, Joshi A, Hozak RR, Xu Y, Ancukiewicz M, Jain RK, Nugent F, Duda DG, Stuart K.	Clin Cancer Res.	2013
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, Szombati I, Esfandiari E, Sleeman MA, Kane CD, Cavet G, Wang B, Godwood A, Magrini F; EARTH Study Group.	Ann Rheum Dis.	2013
View All

Please Sign In